September 24, 2017 10:18 AM ET

Life Sciences Tools and Services

Company Overview of Celerion Inc.

Company Overview

Celerion Inc. provides early clinical research services for pharmaceutical and biotechnology companies in the United States and internationally. The company focuses on delivering applied translational medicine to support early drug development decisions. Its services include global clinical research (Phase I and II, and NDA-enabling clinical pharmacology study conduct); clinical pharmacology sciences (modeling and simulation, study design and protocol development, clinical data sciences, biostatistics, pharmacokinetics/pharmacodynamics (PK/PD), and medical writing and reporting); global bioanalytical services (discovery to late stage services with capabilities in small and large drug, and me...

621 Rose Street

Lincoln, NE 68502-2040

United States

Founded in 2010





Key Executives for Celerion Inc.

Chief Executive officer and President
Age: 64
Chief Financial Officer
Chief Cardiologist and Global Medical Director of Cardiac Safety Services
Chief Medical Officer
Vice President of Global Business Development
Compensation as of Fiscal Year 2017.

Celerion Inc. Key Developments

Celerion Appoints Marc Hoffman as Chief Medical Officer

Celerion announced that Dr. Marc Hoffman has joined the company as Chief Medical Officer. Dr. Hoffman will have responsibility for leading the global medical staff and providing medical oversight and expertise to support early clinical research studies. Dr. Hoffman joins Celerion from Patient iP where he served as Chief Medical Officer, providing clinical leadership around Patient iP’s innovative platform, customer programs and related medical affairs activities. Dr. Hoffman brings over 28 years of knowledge and experience as a physician in the pharmaceutical, device, and CRO industries to this role.

Celerion Announces Celexus as a Premier Safety Reporting Tool for Phase I Clinical Trials

Celerion announced a key technology addition to its early clinical development capabilities, Celexus®. Celexus® offers clients a first look at their early clinical research data in real-time, as it is collected in the clinics and laboratories, from a first in class web-based portal. Celexus® is a sophisticated approach to viewing, analyzing and trending clinical data during acquisition. The viewable data includes screening, recruiting, adverse events, clinical laboratory, pharmacodynamics, pharmacokinetic and bioanalytical data. Celexus is directly populated with data from Clinquick®, Celerion's proprietary electronic data acquisition platform that captures source data directly from the clinic, eliminating the need for manual recording and transcription into a secondary electronic capture system. Designed specifically for clients' evolving needs, Celexus provides visual displays and the ability to define parameters to enable faster assessment of trends and identification of potential safety signals. Safety data visualizations include, among many others, vital signs, dosing, adverse events, ECGs and inclusion/exclusion criteria. These visualizations and source data are easily exported into multiple formats for analysis and creation of ad hoc reports. Another highlight of Celexus is the Key Performance Indicator Dashboard which displays the progression of the study with information such as recruitment, deviations, study milestones/timelines, dosing and retention.

Celerion Inc. Presents at BIO-Europe 2015, Nov-02-2015

Celerion Inc. Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Celerion Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at